Insider · CIK 0001585001
Krishna Yeshwant
Files at VERV (Verve Therapeutics, Inc.). First filing -, latest -.
Krishna Yeshwant files SEC Form 4 as director and 10% owner at VERV (Verve Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Krishna Yeshwant has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | UTender of shares Common Stockindirect: By GV 2017 L.P. | -6,108,442 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | UTender of shares Common Stockindirect: By GV 2019 L.P. | -4,260,047 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | UTender of shares Common Stockindirect: By GV 2023, L.P. | -1,800,000 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -136,139 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -42,200 | - | - | 0 | Jul 28, 2025 |
| Jun 5, 2025 | VERV Verve Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +42,200 | $0.00 | $0 | 42,200 | Jun 6, 2025 |
Questions about Krishna Yeshwant
Answered from the filings on this page, as of the latest one.
Is Krishna Yeshwant buying or selling?
Krishna Yeshwant has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Krishna Yeshwant's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Krishna Yeshwant has 0.
Where does Krishna Yeshwant file Form 4?
Krishna Yeshwant has filed Form 4 at VERV (Verve Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.